EffePharm’s Success at SupplySide West 2023

      SHANGHAI, China—EffePharm, the trailblazing biotech company, takes a moment to appreciate the incredible journey experienced at SupplySide West 2023, held at Mandalay Bay in Las Vegas. The event marked the introduction of UthPeak™, a captivating newcomer to the “Uth” series, EffePharm’s esteemed flagship NAD+ booster line.

      The atmosphere at the EffePharm booth was nothing short of lively, with visitors and clients expressing genuine curiosity and enthusiasm for EffePharm’s latest anti-aging innovations. UthPeak™, a patent-pending crystalline NMNH, emerged as a focal point, promising to be the next star in the realm of NAD+ boosters. 

      EffePharm is conducting research and development around the twelve hallmarks of aging, including Uthever® NMN, Uthever® Lipo liposomal NMN, ApiAge™ apigenin, and SuperMide™ Spermidine. The engaging discussions and shared excitement underscored EffePharm’s commitment to creating wellness solutions grounded in clinical evidence.

       

      Effe-IDS (Ingredient Delivery System), introduced during the event, offered a glimpse into the company’s dedication to advancing active ingredient delivery. The system’s use of innovative technologies such as LipoAvail™, EncapCirc™, and CelleSperse™ hinted at a future where bioavailability and functionality are seamlessly optimized.

       

      SupplySide West 2023 served as a platform for EffePharm to connect with industry professionals and enthusiasts, fostering an atmosphere of collaboration and shared exploration. EffePharm is grateful for the warm reception and the opportunity to share its mission of addressing unmet health needs across all age groups. 

       

       

       

       

       

      About EffePharm:

      Established in 2017, EffePharm is a biotechnology company specializing in providing advanced wellness solutions to its global users. EffePharm is grounded in the belief that everyone should have equal access to health and nutrition. The company is a staunch advocate for innovative bioscience applications, enhancing the accessibility of nutrition, and improving the overall quality of life. Through its “Uth series,” featuring products like Uthever® and UthPeak™, which constitute the company’s flagship NAD+ booster line, EffePharm actively pursues the key to unlocking youthfulness through clinically backed evidence. EffePharm has cultivated a portfolio of over 600 global business partners, thereby benefiting millions of consumers on their journeys toward improved health and nutrition.

       

      Media Contact:

      marketing@effepharm.com

  • EffePharm to Launch UthPeak™ at SupplySide West 2023

    EffePharm to Launch UthPeak™ at SupplySide West 2023 New member of the “Uth series” - EffePharm’s flagship NAD+ booster line SHANGHAI, China—Industry leading biotech company EffePharm will unveil its Next-Gen NAD+ Booster, UthPeak™, at booth #4965 during the SupplySide West...
  • Uthever® Supplementation Proved to Mitigate Radiotherapy-induced Damages

    Radiotherapy is one of the main treatment options for many different types of cancers as it has a high success rate in destroying cancerous cells. However, there is no existing way to prevent the inevitable harm caused by the ionizing...
  • Subacute Toxicity of NMN

    The administration of Nicotinamide mononucleotide(NMN) which is a key precursory metabolite of NAD+ has been reported to have remarkable therapeutic effects on age-related diseases. However systemic evaluation pertaining to the subacute toxicity of NMN remains to be determined.   Recently,...
  • Hi Mrs, NMN Helps Pregnancy

    With the increasing, late marriage and late childbirth in China, as well as the two-child policy, and even the looming phenomenon of the third child in some regions, the group of elderly pregnant women has begun to approach the public's...
  • NMN, A Heart Disease Terminator

    As the engine of the human body, the heart occupies an incomparable position in the body. Obligations, however, go hand in hand with responsibilities. The fate of the heart is from birth to work to death, but why is the...
  • What are the changes NMN can visibly make on you?

    Since the nicotinamide mononucleotide (NMN) was found to promote the increase of NAD+ in the body, the scientific research on its anti-aging effect in an endless stream of studies, and some even dubbed it a "longevity drug". However, whether NMN...
  • NMN Has Anti-Aging Potential for Kidneys

    The world’s population of older adults continues to expand at an unprecedented pace. So, there is a need for a better understanding of aging processes to mitigate age-related diseases and disorders. But not all organs age at the same pace,...
  • How does NMN work in Sirtfood Diet?

    It’s common knowledge that health and longevity go hand in hand with diet, which has encouraged many people to pay close attention to what they eat. Although restricting calorie intake and fasting are proven methods to promote weight loss and...
  • Meet us at CPhi 2020 at E5A08

    From 16Dec to 18Dec 2020, Effepharm will attend CPhi 2020 in Shanghai, China. As an exhibitor, our booth will be E5A08 At the expo, Effepharm will introduce its next-generation NMN - Uthever® to our customers and the public. Looking forward...
  • UTHEVER®NMN awarded 2020 Top 10 Hot raw materials in the nutrition and health industry

    2020 Nutrition Health Entrepreneur Conference (NHEC) was hosted in Bejing International Conference center on Nov.22nd, 2020. With the theme of "Embracing the Future of change and Win-win," this annual conference brings together leaders from national ministries and commissions, authoritative experts...
  • Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN Brand Material UTHEVER®

    Asiaceutical Summit & Expo 2020 took place in Guangzhou from October 21st to 23rd. This conference was hosted by the Herbridge, which gathered the experts in foods, beverage and health care industry. Experts provided cutting edge perspectives under the circumstances of...
  • Meet us at Asiaceutical Summit & Expo 2020

    From 21Oct to 23Oct 2020, Effepharm will attend Asiaceutical Summit & Expo 2020 in Guangdong, China. As an exhibitor, our booth will be B17. At the expo, Effepharm will introduce its next-generation NMN - Uthever® to our customers and the...
  • Clinical evidence on the safety of NMN released recently

    Researchers from Keio University and Washington University published a new article on Endocrine Journal. The safety of single dose at 100, 250, and 500 mg NMN was investigated in 10 Japanese men. Clinical findings and parameters, and the pharmacokinetics of NMN metabolites were...
  • Effepharm started new clinical trials on Uthever™ as

    Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to ICTRP ( International Clinical Trials Registry Platform),  the clinical trial on UtheverTM is the largest scale trial on NMN in the world. What’s more, Effepham is the first and the...
  • Effepharm announced acquisitions and new R&D center establishment

    Effepharm acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has significantly enhanced our R&D capability in anti-aging and energy metabolism. Also Effepharm’s new R&D center is established. Effepharm’s new R&D center will focus on new pharmaceutical...
  • Effepharm team at ”Hi Japan”

      From 2nd to 4th Oct 2019, Effepharm team participated in Hi Japan Exhibit, the Largest Trade Show for Functional & Health Ingredients in Japan. Effepharm is in line with the purpose of this event. Its Highlights: not only the food...
  • Effepharm team in the Vitafoods Europe 2019

    On 7th May, 2019, Sales team at Effepharm came to vitafoods with latest products and new technology. Booth Position:Sliver Area  No. N189 NMN- Popular NAD+ Precursors CBD- This ingredient is very popular in many Europe countries. Effepharm’s R&D has scheduled...
  • New Laboratory has been completed!

    Effepharm Ltd. currently not only holds a strong R&D team consisting of experienced  PHDs and Postdocs returned from abroad, but also employs senior professors and  scholars at home and abroad as a team of research consultants to help us optimize ...
  • Meet Us at the Vitafoods Europe 2019!

      May. 2019, Effepharm teams will participate in Vitafoods Europe 2019 Exhibit, a annual event where the global  nutraceutical supply chain come to gether to do business At that time, Effepharm teams will be waiting for your inquiry and cooperation...
  • “Once-in-two-lifetimes Ingredients”–NMN or NR?

    “Once-in-two-lifetimes Ingredients”--NMN or NR? Nowadays, the people all over the world spend billions of dollars on anti-aging products. While most anti-aging products try to reverse signs of aging on your skin, Nicotinamide Rboside aims to reverse signs of aging from inside your...
  • Sales Office transferred to Shanghai

    Sales Office transferred to Shanghai The sales office was transferred to Shanghai in 2017-EffePharm(Shanghai)Co.,Ltd At Effepharm, we apply science and technologies to improve health and well-being at every stage of life with innovative thinking. Our dedicated team strive to set...